FDA Warns Of High Mortality Rate For Medtronic Stent
Patients using Medtronic Inc.'s AneuRx stent graft system have a higher mortality rate than previously thought, the U.S. Food and Drug Administration announced this week....To view the full article, register now.
Already a subscriber? Click here to view full article